FDA tells OGS that Vevesca is not approvable for Gaucher's.
June 26, 2002
|
Molecular sticking point highlights target for atherosclerosis drugs.
June 26, 2002
|
European drug industry warns of collapse without support.
June 26, 2002
|
Genset says suitor might offer cash for purchase of company.
June 26, 2002
|
Active Biotech AB. (Other News To Note).
June 26, 2002
|
Alizyme plc. (Other News To Note).
June 26, 2002
|
Amedis Pharmaceuticals Ltd., of Cambridge, UK, agreed to a collaborati...
June 26, 2002
|
BioVex Ltd. (Other News To Note).
June 26, 2002
|
Charles River Laboratories International Inc., of Wilmington, Mass., s...
June 26, 2002
|
Devgen NV. (Other News To Note).
June 26, 2002
|
GeneScan Analytics GmbH, of Freiburg, Germany, signed a global coopera...
June 26, 2002
|
Danish start-up focusing on role of hypothalamus in obesity.
June 26, 2002
|
Royalty Pharma cancels IPO, cites poor market conditions.
June 26, 2002
|
Modex completes Phase I Allox trial, eyes industry consolidation.
June 26, 2002
|
Life sciences receive only 3 of 12 new BIRD-F projects.
June 26, 2002
|
Galapagos awarded research grants totaling $3.8 million.
June 26, 2002
|
Protherics plc. (Other News To Note).
June 26, 2002
|
Vernalis Group plc, of Winnersh, UK, said it received a milestone paym...
June 26, 2002
|
German BioChance program funds six start-up companies.
June 19, 2002
|
Cancer genome project strikes gold with melanoma mutation.
June 19, 2002
|
European Parliament finalizes biotechnology research plan.
June 19, 2002
|
Europeans must trust leaders before they believe in biotech. (BIO 2002...
June 19, 2002
|
Antisoma plc. (Other News To Note).
June 19, 2002
|
Astex Technology plc, of Cambridge, UK, announced a third deal around ...
June 19, 2002
|
Cambridge Antibody Technology Group plc, of Melbourn, UK, said the fir...
June 19, 2002
|
MediGene AG. (Other News To Note).
June 19, 2002
|
Oxford Biomedica plc. (Other News To Note).
June 19, 2002
|
ReGen Therapeutics. (Other News To Note).
June 19, 2002
|
Xenova Group plc. (Other News To Note).
June 19, 2002
|
Contral Pharma secures 15m [euro], keeps Biotie merger on track.
June 19, 2002
|
Merck chief considers building in U.S. rather than Germany.
June 19, 2002
|
EU launches proposal regarding controls on human tissues, cells.
June 19, 2002
|
Genfit development plan calls for trials by end of next year.
June 19, 2002
|
YM BioSciences Inc., of Mississauga, Ontario, fell well short of its t...
June 19, 2002
|
IDM sets up U.S. operation, signs second agreement with Medarex.
June 19, 2002
|
E&Y report: firms finding ways to thrive in downturn.
June 12, 2002
|
French researchers find pathway with Huntington's implications.
June 12, 2002
|
CeNeS divests test division as part of restructuring.
June 12, 2002
|
ML Labs divesting unit through flotation on AIM.
June 12, 2002
|
IntegraGen locates obesity genes using GenomeHIP.
June 12, 2002
|
Immuno-Designed Molecules SA, of Paris, concluded an antigen productio...
June 12, 2002
|
Modex Therapeutics Ltd. (Other News To Note).
June 12, 2002
|
PanTherix Ltd., of Glasgow, Scotland, agreed to a license deal with GP...
June 12, 2002
|
Proteome Sciences plc. (Other News To Note).
June 12, 2002
|
U3 Pharma AG, of Munich, Germany, agreed to provide cell assays to Evo...
June 12, 2002
|
Vectura Ltd., of Bath, UK, licensed its pulmonary drug formulation tec...
June 12, 2002
|
TopoTarget acquires Prolifix for cash, stock; raises $15.3m.
June 12, 2002
|
Chromosome-cap projections form targets for cancer drugs.
June 12, 2002
|
Curacyte, VitaResc merging as part of German consolidation.
June 12, 2002
|
Stem cell research moves forward around the world. (BIO 2002 Internati...
June 12, 2002
|
Genmab, Roche expand deal to develop antibody drugs.
June 12, 2002
|
Acambis plc, of Cambridge, UK, said it received 7 million [pounds ster...
June 12, 2002
|
Autogen Ltd. (Other News To Note).
June 12, 2002
|
Israeli government selects two winners for biotech incubators.
June 12, 2002
|
Direvo Biotech AG, of Cologne, Germany, disclosed a three-year collabo...
June 12, 2002
|
Genset SA. (Other News To Note).
June 12, 2002
|
Pharmagene extends Argenta collaboration, shifts focus.
June 05, 2002
|
Australian federal government officials awarded A$46.5 million (US$26....
June 05, 2002
|
British Biotech plc, of Oxford, UK, said it was granted approval in th...
June 05, 2002
|
Crucell NV, of Leiden, the Netherlands, said it granted an exclusive l...
June 05, 2002
|
Cytomyx plc, of Cambridge, UK, signed a contract with M-phasys AG, of ...
June 05, 2002
|
Evotec OAI AG, of Hamburg, Germany, entered a drug discovery collabora...
June 05, 2002
|
French researchers discover new actor in genome assembly.
June 05, 2002
|
UK body proposes criminalizing misuse of genetic information.
June 05, 2002
|
Medivir moving MIV-310 to Phase IIa trial in resistant HIV.
June 05, 2002
|
GeneScan Europe AG. (Other News To Note).
June 05, 2002
|
German Federal Ministry of Education and Research. (Other News To Note...
June 05, 2002
|
Proteome Sciences paying 12.6m [pounds sterling] for Aventis' Proteomi...
June 05, 2002
|
Gyros AB, of Uppsala, Sweden, said it entered an agreement with Kratos...
June 05, 2002
|
Isogenica Ltd., of Cambridge, UK, signed a deal with Invitrogen Corp.,...
June 05, 2002
|
EU ministers formally approve biotechnology research program.
June 05, 2002
|
Population data analysis holds lessons for vaccine designers.
June 05, 2002
|
Novuspharma acquires rights to anti-angiogenesis program.
June 05, 2002
|
Merck scouts Israeli market for promising compounds.
June 05, 2002
|
Wilex, German universities start Phase III to assess uPA's utility.
June 05, 2002
|
